Reuters logo
BRIEF-Dechra Pharmaceuticals says full-year revenue up at 359.3 mln stg
September 4, 2017 / 6:22 AM / in 2 months

BRIEF-Dechra Pharmaceuticals says full-year revenue up at 359.3 mln stg

Sept 4 (Reuters) - Dechra Pharmaceuticals Plc:

* Preliminary results announcement -year end 30.6.17

* Fy revenue growth of 28.3% at constant exchange rates (cer)

* Fy underlying diluted eps growth of 35.1%; increase in full year dividend to 21.44 pence

* Current trading is in line with board expectations and we anticipate delivering our strategic objectives in new financial year

* In year, dechra delivered consolidated revenue of £359.3 million, representing an increase of 28.3% on prior year

* Consolidated underlying operating profit of £81.3 million, represents a 36.9% increase on prior year

* Underlying ebit margin increased by 140bps to 22.6% Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below